SI1255754T1 - Linezolid-kristalna oblika II - Google Patents

Linezolid-kristalna oblika II

Info

Publication number
SI1255754T1
SI1255754T1 SI200130405T SI200130405T SI1255754T1 SI 1255754 T1 SI1255754 T1 SI 1255754T1 SI 200130405 T SI200130405 T SI 200130405T SI 200130405 T SI200130405 T SI 200130405T SI 1255754 T1 SI1255754 T1 SI 1255754T1
Authority
SI
Slovenia
Prior art keywords
linezolid
crystal form
crystal
Prior art date
Application number
SI200130405T
Other languages
English (en)
Slovenian (sl)
Inventor
Michael S Bergren
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22658183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1255754(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of SI1255754T1 publication Critical patent/SI1255754T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SI200130405T 2000-02-02 2001-01-29 Linezolid-kristalna oblika II SI1255754T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17983700P 2000-02-02 2000-02-02
PCT/US2001/000657 WO2001057035A1 (en) 2000-02-02 2001-01-29 Linezolid-crystal form ii
EP01904805A EP1255754B1 (en) 2000-02-02 2001-01-29 Linezolid-crystal form ii

Publications (1)

Publication Number Publication Date
SI1255754T1 true SI1255754T1 (sl) 2005-12-31

Family

ID=22658183

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200130405T SI1255754T1 (sl) 2000-02-02 2001-01-29 Linezolid-kristalna oblika II

Country Status (30)

Country Link
EP (1) EP1255754B1 (enExample)
JP (1) JP5235256B2 (enExample)
KR (3) KR100781815B1 (enExample)
CN (1) CN1221547C (enExample)
AR (1) AR027261A1 (enExample)
AT (1) ATE297920T1 (enExample)
AU (1) AU782138B2 (enExample)
BR (1) BR0107667A (enExample)
CA (1) CA2395603C (enExample)
CO (1) CO5261555A1 (enExample)
CZ (1) CZ302292B6 (enExample)
DE (1) DE60111497T2 (enExample)
DK (1) DK1255754T3 (enExample)
EA (1) EA004434B1 (enExample)
EE (1) EE05197B1 (enExample)
ES (1) ES2242728T3 (enExample)
HU (1) HUP0301076A3 (enExample)
IL (1) IL151010A0 (enExample)
MX (1) MXPA02007471A (enExample)
MY (1) MY122829A (enExample)
NO (2) NO323459B1 (enExample)
NZ (1) NZ520541A (enExample)
PE (1) PE20011086A1 (enExample)
PL (1) PL356433A1 (enExample)
PT (1) PT1255754E (enExample)
SI (1) SI1255754T1 (enExample)
SK (1) SK287025B6 (enExample)
TW (1) TWI297687B (enExample)
WO (1) WO2001057035A1 (enExample)
ZA (1) ZA200205162B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100490643B1 (ko) * 2002-10-29 2005-05-19 한국과학기술연구원 새로운 메틸리덴 피페리딘일 옥사졸리딘온 유도체 및이들의 제조방법
ES2803516T3 (es) 2003-10-16 2021-01-27 Symed Labs Ltd Una forma cristalina de linezolid
ES2294494T3 (es) 2004-04-19 2008-04-01 Symed Labs Limited Un nuevo procedimiento para la preparacion de linezolid y compuestos relacionados.
EP1658275A1 (en) * 2004-06-29 2006-05-24 Teva Pharmaceutical Industries Ltd Crystalline form iv of linezolid
EP1745028A2 (en) * 2004-06-29 2007-01-24 Teva Pharmaceutical Industries Ltd Solid forms of linezolid and processes for preparation thereof
WO2006091731A2 (en) * 2005-02-24 2006-08-31 Teva Pharmaceutical Industries Ltd. Processes for the preparation of linezolid intermediate
KR20070062504A (ko) * 2005-06-22 2007-06-15 테바 파마슈티컬 인더스트리즈 리미티드 테가세로드 말레이트의 다형태
DK1749517T3 (da) * 2005-07-20 2008-11-03 Teva Pharma Stabil farmaceutiske sammensætning af linezolid form IV
WO2007102082A1 (en) * 2006-03-09 2007-09-13 Glenmark Pharmaceuticals Limited High oxazolidinone content solid dosage forms
WO2008127300A2 (en) * 2006-10-23 2008-10-23 Concert Pharmaceuticals Inc. Oxazolidinone derivatives and methods of use
WO2011050826A1 (en) 2009-10-28 2011-05-05 Synthon B.V. Process for making crystalline form a of linezolid
CN103025730A (zh) 2010-04-30 2013-04-03 印第安纳大学研究及科技有限公司 制备利奈唑胺的方法
EP2690100A1 (en) 2010-08-11 2014-01-29 Synhton B.V. Process for making linezolid
WO2012019632A1 (en) 2010-08-11 2012-02-16 Synthon B.V. Process for making linezolid
EP2593440A1 (en) * 2011-02-24 2013-05-22 Lee Pharma Limited Anhydrous linezolid crystalline form-ii
WO2012119653A1 (en) 2011-03-09 2012-09-13 Synthon Bv Process for making crystalline form a of linezolid
CN102731341A (zh) * 2011-04-13 2012-10-17 上海医药工业研究院 用于制备利奈唑胺的中间体及其制备方法
CN105461648B (zh) * 2011-05-03 2018-01-12 江苏豪森药业集团有限公司 利奈唑胺的晶型及其制备方法
CN102399200B (zh) * 2011-12-14 2013-12-04 浙江新东港药业股份有限公司 一种利用悬浮结晶法制备利奈唑胺晶型ⅰ的方法
WO2013111048A1 (en) 2012-01-24 2013-08-01 Jubilant Life Sciences Limited Improved process for the preparation of stable crystalline form-i of linezolid, substantially free of residual solvent
WO2013120496A1 (en) 2012-02-14 2013-08-22 Pharmathen S.A. Process for the preparation of linezolid in crystalline form and salts thereof
CN102643245A (zh) * 2012-04-10 2012-08-22 杭州华东医药集团生物工程研究所有限公司 一种利奈唑胺晶型及其制备方法
ES2603252T3 (es) 2012-11-09 2017-02-24 Synthon Bv Proceso para preparar linezolid
US20190343761A1 (en) 2016-11-16 2019-11-14 Persica Pharmaceuticals Ltd. Antibiotic formulations for lower back pain
EP3709970B1 (en) * 2017-11-16 2025-05-14 Persica Pharmaceuticals Ltd. Linezolid formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
SG85683A1 (en) * 1996-04-11 2002-01-15 Upjohn Co Process to prepare oxazolidinones
NZ504372A (en) * 1997-11-07 2002-12-20 Upjohn Co Process to produce N-[3-fluoro-4(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinones

Also Published As

Publication number Publication date
CN1221547C (zh) 2005-10-05
NO323459B1 (no) 2007-05-14
WO2001057035A1 (en) 2001-08-09
SK9942002A3 (en) 2002-11-06
CZ302292B6 (cs) 2011-02-09
CO5261555A1 (es) 2003-03-31
PT1255754E (pt) 2005-11-30
PL356433A1 (en) 2004-06-28
ZA200205162B (en) 2003-09-29
CA2395603C (en) 2010-03-23
ES2242728T3 (es) 2005-11-16
DK1255754T3 (da) 2005-08-22
MXPA02007471A (es) 2002-12-13
SK287025B6 (sk) 2009-10-07
NO20023654D0 (no) 2002-08-01
AU782138B2 (en) 2005-07-07
EE200200420A (et) 2003-12-15
MY122829A (en) 2006-05-31
CN1394207A (zh) 2003-01-29
KR100781815B1 (ko) 2007-12-03
JP5235256B2 (ja) 2013-07-10
KR20020072300A (ko) 2002-09-14
JP2003522175A (ja) 2003-07-22
NZ520541A (en) 2004-02-27
EP1255754B1 (en) 2005-06-15
DE60111497T2 (de) 2006-05-18
KR20070087178A (ko) 2007-08-27
EE05197B1 (et) 2009-08-17
ATE297920T1 (de) 2005-07-15
NO20023654L (no) 2002-08-01
HK1051196A1 (en) 2003-07-25
KR100864745B1 (ko) 2008-10-22
PE20011086A1 (es) 2001-10-04
TWI297687B (en) 2008-06-11
KR20080044358A (ko) 2008-05-20
AR027261A1 (es) 2003-03-19
IL151010A0 (en) 2003-02-12
AU3275501A (en) 2001-08-14
NO20065836L (no) 2002-08-01
EA004434B1 (ru) 2004-04-29
HUP0301076A3 (en) 2004-06-28
CA2395603A1 (en) 2001-08-09
EA200200819A1 (ru) 2003-02-27
DE60111497D1 (de) 2005-07-21
HUP0301076A2 (hu) 2003-08-28
CZ20022635A3 (cs) 2002-10-16
EP1255754A1 (en) 2002-11-13
BR0107667A (pt) 2002-10-08

Similar Documents

Publication Publication Date Title
DE50112082D1 (en) Bulk-acoustic-wave-filter
DE60115644D1 (en) Thiazinoxazolidinon
DE50104081D1 (en) Hydrolager
AU3391801A (en) Pyridinylimidazoles
PL359920A1 (en) 4-amino-quinazolines
AU8274301A (en) Electro-powder
DE50105205D1 (en) Creatinin-biosensor
IL151010A0 (en) Linezolid-crystal form ii
AU6803901A (en) Bis-arylsulfones
DE50112740D1 (en) Strangführungselement
DE50110569D1 (en) Substituierte c-cyclohexylmethylamin-derivate
DE50107376D1 (en) Orientierte acrylathotmelts
DE50107703D1 (en) Creatininsensor-kalibration
DE50102859D1 (en) Hochfliessfähige propylenblockcopolymerisate
DE50112014D1 (en) Stiftheizer
AU6619001A (en) Liquid-pourers
AU9385201A (en) Sulfonylguanidine
DE50008626D1 (en) Substituierte aminomethyl-phenyl-cyclohexanderivate
DE50114303D1 (en) Nsaugluftkanal
DE60114837D1 (en) Signalmessung
DE50008447D1 (en) Aminomethyl-phenyl-cyclohexanonderivate
DE50114375D1 (en) Compound-reibungsvakuumpumpe
AU9187601A (en) Triazolo-epothilones
AU4686401A (en) Hypotensors
DE50100877D1 (en) Thermoverformbares verbundmaterial